Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 25 studies | 27% ± 10% | |
naive B cell | 16 studies | 30% ± 10% | |
memory B cell | 15 studies | 22% ± 6% | |
plasmacytoid dendritic cell | 12 studies | 31% ± 9% | |
microglial cell | 8 studies | 40% ± 14% | |
macrophage | 7 studies | 29% ± 10% | |
precursor B cell | 5 studies | 57% ± 14% | |
immature B cell | 5 studies | 45% ± 8% | |
astrocyte | 5 studies | 24% ± 9% | |
pro-B cell | 3 studies | 26% ± 7% | |
GABAergic neuron | 3 studies | 23% ± 2% | |
glutamatergic neuron | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 88% | 1098.85 | 854 / 966 | 80% | 16.83 | 422 / 527 |
brain | 91% | 340.43 | 2410 / 2642 | 68% | 2.68 | 478 / 705 |
thymus | 83% | 322.48 | 542 / 653 | 75% | 2.80 | 451 / 605 |
skin | 70% | 326.05 | 1269 / 1809 | 78% | 4.00 | 367 / 472 |
lung | 99% | 836.90 | 574 / 578 | 41% | 0.87 | 468 / 1155 |
breast | 79% | 320.66 | 363 / 459 | 55% | 1.30 | 615 / 1118 |
spleen | 100% | 3487.56 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3024.90 | 922 / 929 | 0% | 0 | 0 / 0 |
bladder | 57% | 210.10 | 12 / 21 | 37% | 5.32 | 185 / 504 |
uterus | 65% | 251.70 | 111 / 170 | 28% | 0.83 | 129 / 459 |
lymph node | 0% | 0 | 0 / 0 | 93% | 26.60 | 27 / 29 |
stomach | 30% | 76.41 | 107 / 359 | 63% | 13.31 | 181 / 286 |
prostate | 77% | 297.65 | 189 / 245 | 14% | 0.23 | 72 / 502 |
adipose | 87% | 394.72 | 1044 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 66% | 172.45 | 169 / 258 | 3% | 0.06 | 7 / 230 |
kidney | 37% | 116.54 | 33 / 89 | 28% | 0.50 | 254 / 901 |
esophagus | 37% | 84.93 | 540 / 1445 | 26% | 0.49 | 47 / 183 |
blood vessel | 62% | 257.30 | 822 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 14% | 34.07 | 47 / 328 | 43% | 1.06 | 76 / 178 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.28 | 23 / 45 |
ovary | 13% | 26.94 | 24 / 180 | 26% | 0.46 | 112 / 430 |
liver | 24% | 65.14 | 55 / 226 | 7% | 0.19 | 29 / 406 |
heart | 18% | 43.54 | 156 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.12 | 6 / 80 |
muscle | 2% | 4.89 | 19 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070873 | Biological process | regulation of glycogen metabolic process |
GO_0061910 | Biological process | autophagosome-endosome fusion |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_0097352 | Biological process | autophagosome maturation |
GO_0006629 | Biological process | lipid metabolic process |
GO_0061909 | Biological process | autophagosome-lysosome fusion |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
GO_0005515 | Molecular function | protein binding |
GO_0010314 | Molecular function | phosphatidylinositol-5-phosphate binding |
GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
Gene name | RUBCNL |
Protein name | Protein associated with UVRAG as autophagy enhancer (Pacer) (Protein Rubicon-like) Rubicon like autophagy enhancer Protein-associated with UVRAG as autophagy enhancer |
Synonyms | KIAA0226L C13orf18 |
Description | FUNCTION: Regulator of autophagy that promotes autophagosome maturation by facilitating the biogenesis of phosphatidylinositol 3-phosphate (PtdIns(3)P) in late steps of autophagy . Acts by antagonizing RUBCN, thereby stimulating phosphatidylinositol 3-kinase activity of the PI3K/PI3KC3 complex . Following anchorage to the autophagosomal SNARE STX17, promotes the recruitment of PI3K/PI3KC3 and HOPS complexes to the autophagosome to regulate the fusion specificity of autophagosomes with late endosomes/lysosomes . Binds phosphoinositides phosphatidylinositol 3-phosphate (PtdIns(3)P), 4-phosphate (PtdIns(4)P) and 5-phosphate (PtdIns(5)P) . In addition to its role in autophagy, acts as a regulator of lipid and glycogen homeostasis (By similarity). May act as a tumor suppressor (Probable). . |
Accessions | ENST00000378797.6 E7EMA2 ENST00000417405 B7ZBN5 ENST00000676051.1 [Q9H714-6] ENST00000429979.6 [Q9H714-5] ENST00000676063.1 ENST00000439642.1 ENST00000389908.7 [Q9H714-5] ENST00000441284.6 ENST00000378781.7 ENST00000676084.1 ENST00000676114.1 [Q9H714-5] ENST00000378784.8 [Q9H714-3] Q9H714 A0A6Q8PGJ9 ENST00000675992.1 A0A6Q8PFX0 A8XR14 ENST00000676307.1 [Q9H714-5] Q5W050 ENST00000378787.7 [Q9H714-4] A0A0A0MRV7 ENST00000631139.2 [Q9H714-6] A0A6Q8PF39 ENST00000675291.1 A0A6Q8PH05 ENST00000409879.6 ENST00000417405.2 [Q9H714-4] ENST00000675585.1 |